Find Product:

IFN-?, human recombinant
7164-10
Biovision
IFN-?, human recombinant
7164-50
Biovision
Recombinant Human IFN-?
SJC03-01
Amyotop 20µg/vial
Recombinant Human IFN-?
SJC03-02
Amyotop 100µg/vial
Recombinant human IFN-γ
CT280
U-CyTech 50 µg
IFN-gamma, human recombinant
4116-100
Biovision
IFN-gamma, human recombinant
4116-1000
Biovision
IFN-gamma, human recombinant
4116-20
Biovision
IFN-?1, human recombinant
7162-10
Biovision
IFN-?1, human recombinant
7162-50
Biovision
IFN-?2, human recombinant
7163-10
Biovision
IFN-?2, human recombinant
7163-50
Biovision
Recombinant Human IFN ?-2a
SJC01-01
Amyotop 20µg/vial
Recombinant Human IFN ?-2a
SJC01-02
Amyotop 100µg/vial
Recombinant Human IFN ?-2b
SJC02-01
Amyotop 20µg/vial
Recombinant Human IFN ?-2b
SJC02-02
Amyotop 100µg/vial
Recombinant Human IFN-Beta Protein
PROTP01574-3
BosterBio 20ug
Description: Proteins of this family play an important role in inducing non-specific resistance against a broad range of viral infections. They also affect cell proliferation and modulate immune responses. Produced by peripheral blood leukocytes and lymphoblastoid cells, IFNα is an acid stable molecule that signals through IFNα/βR, which is also used by IFNβ. Both IFNs have similar anti-viral activity and regulate expression of MHC class I antigens. IFNα contains four highly conserved cysteine residues which form two disulfide bonds, one of which is necessary for biological activity. Recombinant human IFNβ is an 20.0 kDa protein containing 166 amino acid residues. Due to glycosylation, IFNβ has an approximate MW of 22.3 kDa based on SDS-PAGE gel and Mass Spectrometry. *Human IFN-β(Catalog Number 300-02BC) has replaced Human IFN-β(Catalog Number 300-02B)
Recombinant Human IFN-Gamma Protein
PROTP01579-4
BosterBio 100ug
Description: IFN-γ is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-γ receptors are present in most immune cells, which respond to IFN-γ signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-γ signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulate the antigen-specific phases of the immune response. Additionally, IFN-γ stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-γ species-specific and is biologically active only in human and primate cells. Recombinant human IFN-γ is a 16.8 kDa protein containing 144 amino acid residues.
Recombinant Human IFN-Omega Protein
PROTP05000-1
BosterBio 100ug
Description: IFN-ω is a type I interferon, which can be induced by virus-infected leukocytes. Members of the type I interferon family, which includes IFN-α, IFN-β, and IFN-ω, signal through IFNAR-1/IFNAR-2 receptor complex, and exert antiviral and antiproliferative activities. IFN-ω exhibits about 75% sequence homology with IFN-α, and contains two conserved disulfide bonds, which are necessary for full biological activity. Recombinant Human IFN-ω is a 19.9 kDa protein consisting of 172 amino acid residues.
Recombinant Human IFN gamma Protein
R00393
BosterBio 100ug/vial
Human IFN gamma Recombinant Protein
R00393-7
BosterBio 5ug/vial
Description: IFN-gamma, or type II interferon, is a cytokine that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Human IFN gamma Recombinant Protein is purified IFN gamma produced in yeast.
IFN-alpha 2a, human recombinant
4594-100
Biovision
IFN-alpha 2a, human recombinant
4594-1000
Biovision
IFN-alpha 2a, human recombinant
4594-20
Biovision
IFN-alpha 2b, human recombinant
4595-100
Biovision
IFN-alpha 2b, human recombinant
4595-1000
Biovision
IFN-alpha 2b, human recombinant
4595-20
Biovision
IFN-alpha 1, human recombinant
4596-10
Biovision
IFN-alpha 1, human recombinant
4596-100
Biovision
IFN-alpha 1, human recombinant
4596-1000
Biovision
IFN-beta 1b, human recombinant
4860-10
Biovision
IFN-beta 1b, human recombinant
4860-1000
Biovision
IFN-beta 1b, human recombinant
4860-50
Biovision
Human CellExp? IFN-gamma, human recombinant
7271-10
Biovision
Recombinant Human IFN-alpha/ IFNA1/ IFN Protein, Untagged, E.coli-100ug
QP10403-ec-100ug
EnQuireBio 100ug
Recombinant Human IFN-alpha/ IFNA1/ IFN Protein, Untagged, E.coli-20ug
QP10403-ec-20ug
EnQuireBio 20ug
Recombinant Human IFN-alpha/ IFNA1/ IFN Protein, Untagged, E.coli-250ug
QP10403-ec-250ug
EnQuireBio 250ug
Recombinant Human IFN-alpha/ IFNA1/ IFN Protein, Untagged, E.coli-10ug
QP10404-ec-10ug
EnQuireBio 10ug
Recombinant Human IFN-alpha/ IFNA1/ IFN Protein, Untagged, E.coli-2ug
QP10404-ec-2ug
EnQuireBio 2ug
IFN-gamma, murine recombinant
P1015-.02
ApexBio 20 µg
Description: Interferon-gamma (IFN-?) is a prototype proinflammatory cytokine that is mainly produced by activated T, B and NK cells. IFN-? exists immunoregulatory activities, anti-viral activities, anti-proliferative and proinflammatory activities.
IFN-gamma, murine recombinant
P1015-.1
ApexBio 100 µg
Description: Interferon-gamma (IFN-?) is a prototype proinflammatory cytokine that is mainly produced by activated T, B and NK cells. IFN-? exists immunoregulatory activities, anti-viral activities, anti-proliferative and proinflammatory activities.
IFN-gamma, murine recombinant
P1015-1
ApexBio 1 mg
Description: Interferon-gamma (IFN-?) is a prototype proinflammatory cytokine that is mainly produced by activated T, B and NK cells. IFN-? exists immunoregulatory activities, anti-viral activities, anti-proliferative and proinflammatory activities.
IFN-gamma, murine recombinant
4117-100
Biovision
IFN-gamma, murine recombinant
4117-1000
Biovision
IFN-gamma, murine recombinant
4117-20
Biovision
IFN-gamma, rat recombinant
4118-100
Biovision
IFN-gamma, rat recombinant
4118-1000
Biovision
IFN-gamma, rat recombinant
4118-20
Biovision
IFN gamma Recombinant Protein
40-277-002mg
ProSci 0.02 mg
Description: IFN-γ is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-γ receptors are present in most immune cells, which respond to IFN-γ signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-γ signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulate the antigen-specific phases of the immune response. Additionally, IFN-γ stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-γ species-specific and is biologically active only in human and primate cells. Recombinant human IFN-γ is a 16.7 kDa protein containing 143 amino acid residues.
IFN gamma Recombinant Protein
40-277-01mg
ProSci 0.1 mg
Description: IFN-γ is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-γ receptors are present in most immune cells, which respond to IFN-γ signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-γ signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulate the antigen-specific phases of the immune response. Additionally, IFN-γ stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-γ species-specific and is biologically active only in human and primate cells. Recombinant human IFN-γ is a 16.7 kDa protein containing 143 amino acid residues.
IFN beta Recombinant Protein
40-278-0005mg
ProSci 0.005 mg
Description: Proteins of this family play an important role in inducing non-specific resistance against a broad range of viral infections. They also affect cell proliferation and modulate immune responses. Produced by peripheral blood leukocytes and lymphoblastoid cells, IFNα is an acid stable molecule that signals through IFNα/βR, which is also used by IFNβ. Both IFNs have similar anti-viral activity and regulate expression of MHC class I antigens. IFNα contains four highly conserved cysteine residues which form two disulfide bonds, one of which is necessary for biological activity. Recombinant human IFNβ is an 20.0 kDa protein containing 166 amino acid residues. Due to glycosylation, IFNβ has an approximate MW of 22.3 kDa based on SDS-PAGE gel and Mass Spectrometry.
IFN beta Recombinant Protein
40-278-002mg
ProSci 0.02 mg
Description: Proteins of this family play an important role in inducing non-specific resistance against a broad range of viral infections. They also affect cell proliferation and modulate immune responses. Produced by peripheral blood leukocytes and lymphoblastoid cells, IFNα is an acid stable molecule that signals through IFNα/βR, which is also used by IFNβ. Both IFNs have similar anti-viral activity and regulate expression of MHC class I antigens. IFNα contains four highly conserved cysteine residues which form two disulfide bonds, one of which is necessary for biological activity. Recombinant human IFNβ is an 20.0 kDa protein containing 166 amino acid residues. Due to glycosylation, IFNβ has an approximate MW of 22.3 kDa based on SDS-PAGE gel and Mass Spectrometry.
IFN gamma Recombinant Protein
40-449-002mg
ProSci 0.02 mg
Description: IFN-gamma is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-gamma receptors are present in most immune cells, which respond to IFN-gamma signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-gamma signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulates the antigen-specific phases of the immune response. Additionally, IFN-gamma stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-gamma species-specific and is biologically active only in human and primate cells. Recombinant murine IFN-gamma is a 15.6 kDa protein containing 134 amino acid residues.
IFN gamma Recombinant Protein
40-449-01mg
ProSci 0.1 mg
Description: IFN-gamma is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-gamma receptors are present in most immune cells, which respond to IFN-gamma signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-gamma signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulates the antigen-specific phases of the immune response. Additionally, IFN-gamma stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-gamma species-specific and is biologically active only in human and primate cells. Recombinant murine IFN-gamma is a 15.6 kDa protein containing 134 amino acid residues.
IFN gamma Recombinant Protein
40-472-002mg
ProSci 0.02 mg
Description: IFN-gamma is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-gamma receptors are present in most immune cells, which respond to IFN-gamma signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-gamma signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulate the antigen-specific phases of the immune response. Additionally, IFN-gamma stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-gamma is species-specific and is biologically active only in human and primate cells. Recombinant rat IFN-gamma is a 15.6 kDa protein containing 135 amino acid residues.
IFN gamma Recombinant Protein
40-472-01mg
ProSci 0.1 mg
Description: IFN-gamma is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-gamma receptors are present in most immune cells, which respond to IFN-gamma signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-gamma signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulate the antigen-specific phases of the immune response. Additionally, IFN-gamma stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-gamma is species-specific and is biologically active only in human and primate cells. Recombinant rat IFN-gamma is a 15.6 kDa protein containing 135 amino acid residues.
IFN-omega Recombinant Protein
40-519-002mg
ProSci 0.02 mg
Description: IFN-omega is a type I interferon, which can be induced by virus-infected leukocytes. Members of the type I interferon family, which includes IFN-a, IFN-B, and IFN-w, signal through IFNAR-1/IFNAR-2 receptor complex, and exert anti-viral and anti-proliferative activities. IFN-omega exhibits about 75% sequence homology with IFN-a, and contains two conserved disulfide bonds, which are necessary for full biological activity. Recombinant Human IFN-omega is a 19.9 kDa protein consisting of 172 amino acid residues.
IFN-omega Recombinant Protein
40-519-01mg
ProSci 0.1 mg
Description: IFN-omega is a type I interferon, which can be induced by virus-infected leukocytes. Members of the type I interferon family, which includes IFN-a, IFN-B, and IFN-w, signal through IFNAR-1/IFNAR-2 receptor complex, and exert anti-viral and anti-proliferative activities. IFN-omega exhibits about 75% sequence homology with IFN-a, and contains two conserved disulfide bonds, which are necessary for full biological activity. Recombinant Human IFN-omega is a 19.9 kDa protein consisting of 172 amino acid residues.
IFN-y Recombinant Protein
40-557
ProSci 0.1 mg
Description: IFN-γ is an acid-labile interferon produced by CD4 and CD8 T lymphocytes as well as activated NK cells. IFN-γ receptors are present in most immune cells, which respond to IFN-γ signaling by increasing the surface expression of class I MHC proteins. This promotes the presentation of antigen to T-helper (CD4+) cells. IFN-γ signaling in antigen-presenting cells and antigen-recognizing B and T lymphocytes regulate the antigen-specific phases of the immune response. Additionally, IFN-γ stimulates a number of lymphoid cell functions including the anti-microbial and anti-tumor responses of macrophages, NK cells, and neutrophils. Human IFN-γ species-specific and is biologically active only in human and primate cells. Recombinant human IFN-γ is a 16.7 kDa protein containing 143 amino acid residues.Manufactured using all non-animal reagents.
IFN gamma Recombinant Protein
91-012
ProSci 0.05 mg
Description: IFN gamma is the major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease. Interferon gamma is produced mainly byT-cells and natural killer cells activated by antigens, mitogens, or alloantigens. It is produced by lymphocytes expressing the surface antigens CD4 and CD8. IFN gamma synthesis is induced by IL-2, FGF-basic, and EGF.
IFN alpha Recombinant Protein
91-329
ProSci 0.05 mg
Description: The Interferon- alpha/ beta Receptor 1 (IFN- alpha/ beta R1) is a receptor which binds Type I Interferons including Interferon- alpha and - beta . It is a cell surface receptor and heteromeric receptor composed of one chain with two subunits referred to as IFNAR1 and IFNAR2. IFN- alpha/ beta R1, in association with IFN- alpha/ beta R2, is required for propagating antiviral signal transduction triggered by IFN- alpha and IFN- beta . IFN- alpha/ beta R1 interacts very weakly or not at all with type 1 interferons and does not stably interact with IFN- alpha/ beta R2. Ligands associate with IFN- alpha/ beta R2, and this complex subsequently forms a stable ternary assembly with IFN- alpha/ beta R1. IFN- alpha/ beta R1 also associates with IFN- gamma R2 even in the absence of IFN- gamma stimulation. Human IFN- alpha/ beta R1 contains a nuclear localization signal in its extracellular domain that is required for receptor translocation to the nucleus following interaction with ligand. Interferon stimulation results in an immunologic response that is especially associated with viruses.
IFN alpha Recombinant Protein
91-431
ProSci 0.05 mg
Description: Interferon alpha/ beta Receptor 2 (IFN- alpha/ beta R2) is a single-pass type I membrane protein which belongs to the type II cytokine receptor family. It complexes with IFN- alpha/ beta R1 to form the signaling receptor complex for the family of alpha and beta IFN subtypes. By alternative splicing, IFN- alpha/ beta R2 can exist as a secreted soluble protein or as a type I membrane protein. IFN- alpha/ beta R2 is the principal ligand binding subunit of the receptor. Ligand binding is stabilized by the subsequent association with IFN- alpha/ beta R1, resulting in the formation of a signaling ternary receptor complex. IFNAR2 was detected in most lymphocytes, monocytes, and granulocytes, although IFNAR2 expression was higher in the monocytes and granulocytes than in the lymphocytes. Among the lymphocyte subsets, IFNAR2 showed high expression in natural killer (NK) cells and low expression in T lymphocytes. Isoform 1 and isoform 3 of IFNAR2 are directly involved in signal transduction due to their interaction with the TYR kinase, JAK1. Isoform 1 also interacts with the transcriptional factors, STAT1 and STAT2. Both forms are potent inhibitors of type I IFN activity.
IFN gamma Recombinant Protein
91-591
ProSci 0.05 mg
Description: Mouse Ifng is a secreted protein which belongs to the type I I (or gamma) interferon family. IFNG is produced by lymphocytes and activated by specific antigens or mitogens. In addition to having antiviral activity, IFNG also has important immunoregulatory functions. It is a potent activator of macrophages and has antiproliferative effects on transformed cells. It can potentiate the antiviral and antitumor effects of the type I interferons. Genetic variation in IFNG is associated with the risk of aplastic anemia (AA) which is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis.
IFN alpha Recombinant Protein
91-885
ProSci 0.05 mg
Description: Interferon alpha/ beta Receptor 2 (IFN- alpha/ beta R2) is a single-pass type I membrane protein which belongs to the type II cytokine receptor family. It complexes with IFN- alpha/ beta R1 to form the signaling receptor complex for the family of alpha and beta IFN subtypes. By alternative splicing, IFN- alpha/ beta R2 can exist as a secreted soluble protein or as a type I membrane protein. IFN- alpha/ beta R2 is the principal ligand binding subunit of the receptor. Ligand binding is stabilized by the subsequent association with IFN- alpha/ beta R1, resulting in the formation of a signaling ternary receptor complex. IFNAR2 was detected in most lymphocytes, monocytes, and granulocytes, although IFNAR2 expression was higher in the monocytes and granulocytes than in the lymphocytes. Among the lymphocyte subsets, IFNAR2 showed high expression in natural killer (NK) cells and low expression in T lymphocytes. Isoform 1 and isoform 3 of IFNAR2 are directly involved in signal transduction due to their interaction with the TYR kinase, JAK1. Isoform 1 also interacts with the transcriptional factors, STAT1 and STAT2. Both forms are potent inhibitors of type I IFN activity.
IFN gamma Recombinant Protein
92-362
ProSci 0.05 mg
Description: IFN gamma is the major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease. Interferon gamma is produced mainly byT-cells and natural killer cells activated by antigens, mitogens, or alloantigens. It is produced by lymphocytes expressing the surface antigens CD4 and CD8. IFN gamma synthesis is induced by IL-2, FGF-basic, and EGF.
IFN gamma Recombinant Protein
92-632
ProSci 0.05 mg
Description: Mouse Ifng is a secreted protein which belongs to the type I I (or gamma) interferon family. IFNG is produced by lymphocytes and activated by specific antigens or mitogens. In addition to having antiviral activity, IFNG also has important immunoregulatory functions. It is a potent activator of macrophages and has antiproliferative effects on transformed cells. It can potentiate the antiviral and antitumor effects of the type I interferons. Genetic variation in IFNG is associated with the risk of aplastic anemia (AA) which is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis.
IFN gamma Recombinant Protein
92-633
ProSci 0.05 mg
Description: Mouse Ifng is a secreted protein which belongs to the type I I (or gamma) interferon family. IFNG is produced by lymphocytes and activated by specific antigens or mitogens. In addition to having antiviral activity, IFNG also has important immunoregulatory functions. It is a potent activator of macrophages and has antiproliferative effects on transformed cells. It can potentiate the antiviral and antitumor effects of the type I interferons. Genetic variation in IFNG is associated with the risk of aplastic anemia (AA) which is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis.
Recombinant Human IFN-Lambda 1 Protein
PROTQ8IU54-4
BosterBio 20ug
Description: IFN λ-1,-2, and -3 (also known as IL-29, IL-28A and IL-28B respectively) are distantly related to the IL-10 family and Interferons. All three IFN-λs use a distinct receptor system composed of an IFN-λR1 subunit (also called CRF2-12) and IL-10R2 subunit (also called CRF2-14). Signaling through this receptor system induces antiviral defense similar but distinct than the type I Interferons. (Kotenko, SV. et al. Nat Immunology 2003 [1] p. 69-77). Recombinant human IFN-λ 1 is a 19.8 kDa protein containing 178 amino acid residues.
Recombinant Human IFN-Lambda 2 Protein
PROTQ8IZJ0-3
BosterBio 20ug
Description: IFN -λ-1,-2, and -3 (also known as IL-29, IL-28A and IL-28B respectively) are distantly related to the IL-10 family and Interferons. All three IFN-λs uses a distinct receptor system composed of an IFN-λR1 subunit (also called CRF2-12) and IL-10R2 subunit (also called CRF2-14). Signaling through this receptor system induces antiviral defense similar but distinct than the type I Interferons.(Kotenko, SV. et al. Nat Immunology 2003 [1] p. 69-77). Recombinant human IFN-λ 2 is a 19.6 kDa protein containing 174 amino acid residues.
IFN-alpha 1, human recombinant protein
P1058-.01
ApexBio 10 µg
Description: IFN-?1 (also called IFN-?) is a lymphoid factor with potent antiviral antiproliferative and immunomodulatory properties. Human IFN-?1 is a 19.3 kDa protein containing 166 amino acid residues.
IFN-alpha 1, human recombinant protein
P1058-.1
ApexBio 100 µg
Description: IFN-?1 (also called IFN-?) is a lymphoid factor with potent antiviral antiproliferative and immunomodulatory properties. Human IFN-?1 is a 19.3 kDa protein containing 166 amino acid residues.
IFN-alpha 1, human recombinant protein
P1058-1
ApexBio 1 mg
Description: IFN-?1 (also called IFN-?) is a lymphoid factor with potent antiviral antiproliferative and immunomodulatory properties. Human IFN-?1 is a 19.3 kDa protein containing 166 amino acid residues.
Recombinant Human Interferon γ/IFN-γ
CI57-10ug
Novoprotein 10ug
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.0.
Recombinant Human Interferon γ/IFN-γ
CI57-1mg
Novoprotein 1mg
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.0.
Recombinant Human Interferon γ/IFN-γ
CI57-500ug
Novoprotein 500ug
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.0.
Recombinant Human Interferon γ/IFN-γ
CI57-50ug
Novoprotein 50ug
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.0.
Recombinant Human IFN-alpha/ IFNA1/ IFN Protein, His-SUMO, E.coli-100ug
QP7402-ec-100ug
EnQuireBio 100ug
Recombinant Human IFN-alpha/ IFNA1/ IFN Protein, His-SUMO, E.coli-10ug
QP7402-ec-10ug
EnQuireBio 10ug
Recombinant Human IFN-alpha/ IFNA1/ IFN Protein, His-SUMO, E.coli-1mg
QP7402-ec-1mg
EnQuireBio 1mg
Recombinant Human IFN-alpha/ IFNA1/ IFN Protein, His-SUMO, E.coli-200ug
QP7402-ec-200ug
EnQuireBio 200ug
Recombinant Human IFN-alpha/ IFNA1/ IFN Protein, His-SUMO, E.coli-500ug
QP7402-ec-500ug
EnQuireBio 500ug
Recombinant Human IFN-alpha/ IFNA1/ IFN Protein, His-SUMO, E.coli-50ug
QP7402-ec-50ug
EnQuireBio 50ug
IFN-b IFN Beta Mouse Recombinant Protein, His Tag
PROTP01575
BosterBio Regular: 25ug
Description: IFN beta Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 182 amino acids (22-182 a.a.) and having a molecular mass of 22 kDa. Mouse IFN beta is fused to 20 amino acid at N-terminus and purified by proprietary chromatographic techniques.
IFN
EF000134
Lifescience Market 96 Tests
IFN-
EF000320
Lifescience Market 96 Tests
IFN-
EF016614
Lifescience Market 96 Tests
IFN-
EF016615
Lifescience Market 96 Tests
IFN-
EF016616
Lifescience Market 96 Tests
IFN-
EF016810
Lifescience Market 96 Tests
IFN-
EF016941
Lifescience Market 96 Tests
IFN-
EF017015
Lifescience Market 96 Tests
IFN-
EF017827
Lifescience Market 96 Tests
IFN-
EF019502
Lifescience Market 96 Tests
IFN-
EF006926
Lifescience Market 96 Tests
IFN-
EF011053
Lifescience Market 96 Tests
IFN-
EF012037
Lifescience Market 96 Tests
IFN-
EF012611
Lifescience Market 96 Tests
IFN-
EF012612
Lifescience Market 96 Tests
IFN-
EF012702
Lifescience Market 96 Tests
IFN-
EF012703
Lifescience Market 96 Tests

Did not find what you were looking for? Send us request and we will contact with you!